Marks Group Wealth Management, Inc Zai Lab LTD Transaction History
Marks Group Wealth Management, Inc
- $1.02 Billion
- Q2 2025
A detailed history of Marks Group Wealth Management, Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 14,253 shares of ZLAB stock, worth $529,784. This represents 0.05% of its overall portfolio holdings.
Number of Shares
14,253
Previous 10,331
37.96%
Holding current value
$529,784
Previous $373,000
33.51%
% of portfolio
0.05%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ZLAB
# of Institutions
176Shares Held
50.2MCall Options Held
92.9KPut Options Held
318K-
Capital World Investors Los Angeles, CA6.01MShares$223 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$142 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$136 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.28MShares$122 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY3.14MShares$117 Million1.86% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.64B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...